Medpace Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 11, 2025
MEDP$672.93+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Exhibit Index
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber · Exhibit Description · Form · File No. · Exhibit · FilingDate · Filed/FurnishedHerewith | |||||
| 3.1 | Restated Certificate of Incorporation | 8-K | 001-37856 | 3.1 | 5/21/24 |
| 3.2 | Second Amended and Restated Bylaws | 8-K | 001-37856 | 3.2 | 5/21/24 |
| 4.1 | Specimen Stock Certificate evidencing shares of common stock | S-1/A | 333-212236 | 4.1 | 7/26/16 |
| 4.2 | Description of Securities | 10-K | 001-37856 | 4.3 | 2/25/20 |
| #10.1 | Medpace Holdings, Inc. 2016 Incentive Award Plan | 10-Q | 001-37856 | 10.1 | 11/3/16 |
| #10.2 | Medpace Holdings, Inc. 2016 Senior Executive Incentive Bonus Plan | 10-Q | 001-37856 | 10.2 | 11/3/16 |
| 10.3 | Registration Rights Agreement | 10-Q | 001-37856 | 10.3 | 11/3/16 |
| #10.4 | Form of Medpace Holdings, Inc. 2016 Incentive Award Plan Restricted Stock Award Grant Notice | S-1/A | 333-212236 | 10.13 | 8/1/16 |
| #10.5 | Form of Medpace Holdings, Inc. 2016 Incentive Award Plan Stock Option Grant Notice and Stock Option Agreement | 10-Q | 001-37856 | 10.1 | 10/22/24 |
| #10.6 | Form of Medpace Holdings, Inc. 2016 Incentive Award Plan Restricted Stock Unit Award Grant Notice | 10-Q | 001-37856 | 10.2 | 10/22/24 |
| #10.7 | Medpace Holdings, Inc. 2016 Incentive Award Plan Sub-Plan for UK Participants | S-1/A | 333-212236 | 10.16 | 8/1/16 |
| #10.8 | Amended and Restated Employment Agreement, by and between Medpace Holdings, Inc. and August J. Troendle | S-1/A | 333-212236 | 10.18 | 7/26/16 |
| #10.9 | Medpace Holdings, Inc. 2016 Incentive Award Plan UK Company Share Option Plan (CSOP) Sub-Plan | S-1/A | 333-212236 | 10.19 | 8/1/16 |
| #10.10 | Medpace Holdings, Inc. Non-Employee Director Compensation Policy revised October 21, 2022 | 10-K | 001-37856 | 10.10 | 2/14/23 |
| 10.11 | Loan Agreement dated as of September 30, 2019, by and among Medpace, Inc., as borrower, and PNC Bank, National Association. | 8-K | 001-37856 | 10.1 | 10/1/19 |
| 10.12 | Amendment No. 1 dated March 30, 2020 to Loan Agreement dated as of September 30, 2019, by and among Medpace, Inc., as borrower, and PNC Bank, National Association | 8-K | 001-37856 | 10.1 | 4/1/20 |
| 10.13 | Form of Indemnification Agreement | 10-K | 001-37856 | 10.13 | 2/16/21 |
| 10.14 | Amendment No. 2 dated March 29, 2021 to Loan Agreement dated as of September 30, 2019, by and among Medpace, Inc., as borrower, and PNC Bank, National Association | 8-K | 001-37856 | 10.1 | 3/30/21 |
- 82 -
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | Filed/FurnishedHerewith |
| 10.15 | Amendment No. 3 dated December 27, 2021 to Loan Agreement dated as of September 30, 2019, by and among Medpace, Inc., as borrower, and PNC Bank, National Association | 8-K | 001-37856 | 10.1 | 12/29/21 | |
| 10.16 | Amendment No. 4 dated March 15, 2022 to Loan Documents | 8-K | 001-37856 | 10.1 | 3/16/22 | |
| 10.17 | Amendment No. 5 dated March 31, 2023 to Loan Documents | 8-K | 001-37856 | 10.1 | 3/31/23 | |
| 10.18 | Amendment No. 6 dated March 28, 2024 to Loan documents | 8-K | 001-37856 | 10.1 | 3/29/24 | |
| 19.1 | Insider Trading Compliance Policy | 10-K | 001-37856 | 19.1 | 2/13/24 | |
| 21.1 | List of Subsidiaries of Medpace Holdings, Inc. | * | ||||
| 23.1 | Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm | * | ||||
| 31.1 | Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer | * | ||||
| 31.2 | Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer | * | ||||
| 32.1 | Section 1350 Certification of Chief Executive Officer | ** | ||||
| 32.2 | Section 1350 Certification of Chief Financial Officer | ** | ||||
| 97.1 | Incentive Compensation Recoupment Policy | 10-K | 001-37856 | 97.1 | 2/13/24 | |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||
| 101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | * | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | * | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | * | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation | * | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||
- Filed herewith.
** Furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.